SUMO1P3 and hepatocellular carcinoma: Collectively, these results suggested that SUMO1P3 plays critical roles in HCC progression by increasing cell viability, proliferation and invasion, and decreasing cell apoptosis, providing evidence that SUMO1P3 may be a useful prognostic marker and a prospective target for HCC therapy.